SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-15-003704
Filing Date
2015-12-22
Accepted
2015-12-22 16:48:49
Documents
5
Period of Report
2015-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd8-k.htm 8-K 30422
2 FIRST AMENDMENT TO BYLAWS OF THE COMPANY ex3-1.htm EX-3.1 51589
3 EMPLOYMENT AGREEMENT - BERNICK ex10-1.htm EX-10.1 71703
4 EMPLOYMENT AGREEMENT - DONEGAN ex10-2.htm EX-10.2 73715
5 EMPLOYMENT AGREEMENT - KRASSAN ex10-3.htm EX-10.3 74491
  Complete submission text file 0001387131-15-003704.txt   303606
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 151302658
SIC: 2834 Pharmaceutical Preparations